Role of early circulating tumour cell (CTC) monitoring for prediction of clinical outcome in patients with HER-2 negative metastatic breast cancer receiving first-line treatment with bevacizumab and paclitaxel

Simple item page
dc.conference.dateMAY 23-24, 2020
dc.conference.titleESMO Breast Cancer Virtual Meeting
dc.contributor.authorAlvarez-Lopez, I.
dc.contributor.authorGonzalez, E.
dc.contributor.authorManso, L. M.
dc.contributor.authorAlonso, J. L.
dc.contributor.authorCruz-Hernandez, J. J.
dc.contributor.authorCaranana Ballerini, V.
dc.contributor.authorGallegos, I.
dc.contributor.authorQuindos Varela, M.
dc.contributor.authorIllaramendi, J. J.
dc.contributor.authorVicente, E.
dc.contributor.authorBallesteros Garcia, A. I.
dc.contributor.authorAyala de la Pena, F.
dc.contributor.authorPerello, A.
dc.contributor.authorVidal, J.
dc.contributor.authorLlombart Cussac, A.
dc.contributor.authoraffiliation[Alvarez-Lopez, I.] Hosp Univ Donostia Biodonostia, Med Oncol, San Sebastian, Spain
dc.contributor.authoraffiliation[Gonzalez, E.] Hosp Univ Virgen Nieves, Med Oncol, Granada, Spain
dc.contributor.authoraffiliation[Manso, L. M.] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Alonso, J. L.] Hosp Clin Univ Virgen Arrixaca, Med Oncol, El Palmar, Spain
dc.contributor.authoraffiliation[Cruz-Hernandez, J. J.] Hosp Univ Salamanca, Dept Med Oncol, Salamanca, Spain
dc.contributor.authoraffiliation[Caranana Ballerini, V.] Hosp Arnau Vilanova, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Vidal, J.] Hosp Arnau Vilanova, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Llombart Cussac, A.] Hosp Arnau Vilanova, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Gallegos, I.] Hosp Gen Segovia, Med Oncol, Segovia, Spain
dc.contributor.authoraffiliation[Quindos Varela, M.] Hosp Univ A Coruna, Med Oncol, La Coruna, Spain
dc.contributor.authoraffiliation[Illaramendi, J. J.] Hosp Navarra, Med Oncol, Pamplona, Spain
dc.contributor.authoraffiliation[Vicente, E.] Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain
dc.contributor.authoraffiliation[Ballesteros Garcia, A. I.] Hosp Univ La Princesa, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Ayala de la Pena, F.] Hosp Gen Univ Morales Meseguer, Med Oncol, Murcia, Spain
dc.contributor.authoraffiliation[Perello, A.] Hosp Univ Son Espases, Med Oncol, Palma De Mallorca, Spain
dc.contributor.funderRoche Farma S.A.
dc.date.accessioned2025-01-07T14:15:45Z
dc.date.available2025-01-07T14:15:45Z
dc.date.issued2020-05-01
dc.identifier.doi10.1016/j.annonc.2020.03.173
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420362529/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26246
dc.identifier.wosID538879300035
dc.issue.number2
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.page.numberS29-S29
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleRole of early circulating tumour cell (CTC) monitoring for prediction of clinical outcome in patients with HER-2 negative metastatic breast cancer receiving first-line treatment with bevacizumab and paclitaxel
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía